MOL-4239

DB16051InvestigationalSmall molecule

MOL-4239 is under investigation in clinical trial NCT01826201 (Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis).

Chemical structure of MOL-4239
Formula / weight
C19H16BrN3O · 382.261 g/mol (avg)
Code names
MOL-4239 · WP-1220

Resolves to

Compound
UNIIPTN9LJL6PYCAS1204306-34-2
Structure
InChIKeyIVAUEQVCSQZMGV-QIUCFAMLSA-NSMILESC[C@H](NC(=O)C(=C\C=C\C1=CC=CC(Br)=N1)\C#N)C1=CC=CC=C1
Targets
P40763STAT3

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with MOL-4239, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In